Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2012-12-01

Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.

Chanapai Chaiyakulsil, Olarn Prommalikit

Index: J. Med. Assoc. Thai. 95 Suppl 12 , S138-41, (2012)

Full Text: HTML

Abstract

Extended-spectrum beta-lactamase (ESBL) producing organisms cause wide spectrum of diseases including urinary tract infection, cholangitis, intra-abdominal abscess or pneumonia but rarely meningitis. The present report a successful nonsurgical, medical treatment in a child with Escherichia coli ESBL meningitis with acute symptomatic communicating hydrocephalus and ventricular empyema. Incidence of infections from ESBL producing organisms are increasingly emerging and causing wide spectrum of illnesses which prompts for both aggressive medical and surgical intervention to prevent morbidity and mortality. Antimicrobial agents must be vigilantly utilized to prevent possible development of new highly-resistant organisms.


Related Compounds

Related Articles:

A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.

2015-01-01

[Biomed Res. Int. 2015 , 419383, (2015)]

Identification of peptide inhibitors of penicillinase using a phage display library.

2016-02-01

[Anal. Biochem. 494 , 4-9, (2015)]

Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.

2014-03-01

[J. Med. Microbiol. 63(Pt 3) , 386-92, (2014)]

Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.

2012-11-01

[J. Assoc. Physicians India 60 , 22-4, (2012)]

Looking for the new preparations for antibacterial therapy. II. Clinical trials; new beta-lactam antibiotics and beta-lactamase inhibitors.

2013-01-01

[Przegl. Epidemiol. 67(1) , 51-6, 135-40, (2013)]

More Articles...